| Ticker | $ Bought |
|---|---|
| roivant sciences ltd | 14,952,200 |
| imagenebio inc | 4,408,530 |
| immuneering corp | 3,850,000 |
| nu hldgs ltd | 2,783,710 |
| mereo biopharma group plc | 2,575,000 |
| arcellx inc | 2,202,170 |
| kalvista pharmaceuticals inc | 1,522,500 |
| gitlab inc | 556,828 |
| Ticker | % Inc. |
|---|---|
| compass pathways plc | 163 |
| dell technologies inc | 151 |
| ultragenyx pharmaceutical in | 65.51 |
| aquestive therapeutics inc | 35.87 |
| larimar therapeutics inc | 18.77 |
| holley inc | 18.24 |
| cullinan therapeutics inc | 5.24 |
| Ticker | % Reduced |
|---|---|
| tango therapeutics inc | -85.34 |
| mineralys therapeutics inc | -69.95 |
| servicetitan inc | -56.35 |
| centessa pharmaceuticals plc | -48.74 |
| rezolve ai plc | -38.55 |
| eyepoint pharmaceuticals inc | -34.66 |
| eledon pharmaceuticals inc | -26.32 |
| palvella therapeutics inc ne | -23.95 |
| Ticker | $ Sold |
|---|---|
| biomea fusion inc | -2,340,000 |
| cabaletta bio inc | -1,710,000 |
| tourmaline bio inc | -15,943,700 |
| ikena oncology inc | -5,482,100 |
| rezolve ai plc | -558,626 |
| starwood ppty tr inc | -2,638,420 |
| tempus ai inc | -5,093,810 |
| apogee therapeutics inc | -1,520,050 |
Blue Owl Capital Holdings LP has about 40.3% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 40.3 |
| Healthcare | 40.3 |
| Technology | 12.1 |
| Consumer Cyclical | 4.7 |
| Industrials | 2.3 |
Blue Owl Capital Holdings LP has about 2.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 42 |
| SMALL-CAP | 29.7 |
| MID-CAP | 15.2 |
| MICRO-CAP | 9.1 |
| LARGE-CAP | 2.7 |
| NANO-CAP | 1.3 |
About 34.7% of the stocks held by Blue Owl Capital Holdings LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 65.2 |
| RUSSELL 2000 | 34.7 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Blue Owl Capital Holdings LP has 72 stocks in it's portfolio. About 61.7% of the portfolio is in top 10 stocks. CGEM proved to be the most loss making stock for the portfolio. HLLY was the most profitable stock for Blue Owl Capital Holdings LP last quarter.
Last Reported on: 12 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 0.68 | 26,823 | 2,202,170 | new | |||
| ADCT | adc therapeutics sa | 0.91 | 733,568 | 2,934,270 | unchanged | 0.00 | ||
| AQST | aquestive therapeutics inc | 2.17 | 1,250,000 | 6,987,500 | added | 35.87 | ||
| BKSY | blacksky technology inc | 0.02 | 350,000 | 59,045 | unchanged | 0.00 | ||
| BMEA | biomea fusion inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CABA | cabaletta bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CAH | cardinal health inc | 0.08 | 1,718 | 269,657 | unchanged | 0.00 | ||
| CGEM | cullinan therapeutics inc | 4.62 | 2,510,970 | 14,890,100 | added | 5.24 | ||
| CMPS | compass pathways plc | 1.08 | 604,914 | 3,466,160 | added | 163 | ||
| CMPX | compass therapeutics inc | 2.82 | 2,591,520 | 9,070,340 | unchanged | 0.00 | ||
| CNDT | conduent inc | 3.87 | 4,456,850 | 12,479,200 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals plc | 1.28 | 169,450 | 4,109,160 | reduced | -48.74 | ||
| CNTX | context therapeutics inc | 2.23 | 7,407,910 | 7,176,780 | unchanged | 0.00 | ||
| CVEO | civeo corp cda | 2.27 | 317,411 | 7,300,450 | unchanged | 0.00 | ||
| DAVE | dave inc | 0.01 | 28,750 | 31,194 | unchanged | 0.00 | ||
| DELL | dell technologies inc | 2.30 | 52,334 | 7,419,390 | added | 151 | ||
| ELDN | eledon pharmaceuticals inc | 0.79 | 979,912 | 2,537,970 | reduced | -26.32 | ||
| EMLD | fold hldgs inc | 0.45 | 856,632 | 1,445,340 | unchanged | 0.00 | ||
| EPD | enterprise prods partners l | 0.30 | 31,290 | 978,438 | unchanged | 0.00 | ||
| EVCM | evercommerce inc | 5.67 | 1,641,930 | 18,274,700 | unchanged | 0.00 | ||